Global Catheter Related Bloodstream Infection Market Data 2024, Forecast To 2033

22 Aug, 2024

The catheter-related bloodstream infection market has shown strong growth, increasing from $1.44 billion in 2023 to $1.53 billion in 2024, with a CAGR of 5.9%. This historical growth is attributed to the rising incidence of chronic diseases, increased awareness and education, a rise in hospital-acquired infections, a growing elderly population, and enhanced infection control programs. The market is expected to reach $1.93 billion in 2028 at a CAGR of 6.1%, driven by increasing healthcare-associated infections, rising awareness and training, expanded infection control practices, healthcare infrastructure growth, an aging population, and supportive government policies. Major trends include biomaterial innovations, smart catheter technology, more effective catheter lock solutions with advanced antimicrobial properties, innovations in catheter sterilization, and automated flushing systems.

Global Catheter Related Bloodstream Infection Market Key Driver

The increasing prevalence of hospital-acquired infections is expected to drive the growth of the catheter-related bloodstream infection market. Hospital-acquired infections, occurring 48 hours or more after admission, result from factors like antimicrobial resistance, inadequate infection control, and patient susceptibility. Catheter-related bloodstream infections significantly contribute to hospital-acquired infections due to their invasive nature and potential for microbial colonization. The National Library of Medicine reported in January 2023 that the global rate of healthcare-associated infections was 0.14%, with an annual increase of 0.06%. This rising prevalence of hospital-acquired infections is fueling the growth of the catheter-related bloodstream infection market.

Get A Free Sample Of The Catheter Related Bloodstream Infection Market Report

Global Catheter Related Bloodstream Infection Market Segments

The catheter-related bloodstream infection market covered in this report is segmented –
1) By Treatment: Antibiotic Lock Therapy, Anti-Microbial Agents
2) By Source Of Infection Or Causative Agents: Staphylococcus Aureus, Acinetobacter Baumannii, Escherichia Coli (E. Coli), Klebsiella Pneumoniae (K. Pneuminiae), Candida Species (Candida Sp.), Pseudomonas Aeruginosa (P. Aeruginsa), Other Source Of Infection Or Causative Agents
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Geography:The regions covered in the catheter-related bloodstream infection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. North America was the largest region in the catheter-related bloodstream infection market in 2023.

Major Catheter Related Bloodstream Infection Industry Players

Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG, 3M Company, Eli Lilly and Company, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company, Viatris Inc., B. Braun Medical Inc., Aurobindo Pharma Limited, Lupin Ltd., Xellia Pharmaceuticals Ltd., SteriMax Inc., Geistlich Pharma AG, Bactiguard AB, Hetero Healthcare Ltd., TauroPharm GmbH, Advacare Pharma, Citus Pharmaceuticals Inc., CorMedix Inc., JoinHub Pharma LLP, IntegraDose Compounding Services LLC

Purchase The Global Catheter Related Bloodstream Infection Market Report Directly And Get A Swift Delivery

Catheter Related Bloodstream Infection Market Overview

Catheter-related bloodstream infection (CRBSI) is a type of infection that occurs when bacteria or fungi enter the bloodstream through a catheter, a tube inserted into a vein to deliver medications or nutrients. It is a serious healthcare-associated infection that can lead to sepsis and other complications. Prompt diagnosis and treatment are essential to prevent severe outcomes.

Catheter Related Bloodstream Infection Global Market Report 2023 provides data on the global catheter related bloodstream infection market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The catheter related bloodstream infection market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.